RCE 2.33% 44.0¢ recce pharmaceuticals ltd

Recce Pharmaceuticals (ASX:RCE) to dual list on FSE

  1. 7,555 Posts.
    lightbulb Created with Sketch. 1042
    • Recce Pharmaceuticals (RCE) has begun the process to dual list on the Frankfurt Stock Exchange (FSE)
    • The company has appointed Deutsche Gesellschaft Für Wertpapieranalyse (DGWA) as its investor and corporate relations advisor in Europe
    • DGWA will engage prospective investors and drive awareness of Recce's productsDual listing on the FSE will give Recce exposure to multiple retail and institutional investors in the European Union
    • The company will keep the market updated as the listing progresses Shares in Recce are steady on the market and are trading at $1.05 per share

    Read the full article on The Market Herald here.
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
44.0¢
Change
0.010(2.33%)
Mkt cap ! $89.62M
Open High Low Value Volume
43.0¢ 44.0¢ 43.0¢ $24.01K 55.73K

Buyers (Bids)

No. Vol. Price($)
3 72121 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
45.0¢ 29087 2
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
44.0¢
  Change
0.010 ( 2.33 %)
Open High Low Volume
43.5¢ 44.0¢ 43.0¢ 7544
Last updated 15.59pm 28/03/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.